[CORE study].
Mizunuma
Hideki
H
Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine.
D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000517:prevention & control*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage*; D013997:Time Factors
D050071:Bone Density Conservation Agents; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride